Clinical Trials Logo

Clinical Trial Summary

7 to 14 days actimetry recording in order to exclude sleep deprivation just before hospitalisation for differential diagnosis of hypersomnia


Clinical Trial Description

This is an observational study Urine drug screening will also be performe The suty includes four centers in France The study duration is of one year ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03459300
Study type Observational
Source Centre d'Investigation Clinique et Technologique 805
Contact
Status Completed
Phase
Start date February 1, 2018
Completion date January 17, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05983731 - A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1
Completed NCT01183312 - Flumazenil for the Treatment of Primary Hypersomnia Phase 1/Phase 2
Terminated NCT03198156 - Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy N/A
Completed NCT03682185 - The Healthy Patterns Sleep Study Phase 3
Completed NCT00916253 - Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies N/A
Completed NCT04157244 - The Music, Sleep and Dementia Study N/A
Recruiting NCT05443373 - A Multi-Signal Based Monitoring System for CNS Hypersomnias
Completed NCT01877616 - Sleep Disorders and Their Cardiovascular Correlates in Atahualpa. N/A
Suspended NCT00427323 - Light Exposure to Treat Sleep Disruption in Older People N/A
Not yet recruiting NCT04300166 - Telemedicine and Humidification for Cpap IN Osas Key Treatment (THINK Study) N/A
Not yet recruiting NCT06404099 - RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) Phase 2
Not yet recruiting NCT06404086 - RECOVER-SLEEP: Platform Protocol Phase 2
Completed NCT01146600 - Clarithromycin for the Treatment of Hypersomnia Phase 2
Withdrawn NCT05627388 - Feasibility Study of At-Home EEG Monitoring for Hypersomnia N/A
Completed NCT01764035 - Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder N/A
Completed NCT00001664 - Sleep Disorders of Patients With Diseases of the Nervous System N/A
Recruiting NCT04201392 - Sleep in Psychiatric Inpatients
Suspended NCT05230394 - Patient Outcomes in Unattended and In- Lab Polysomnography N/A
Terminated NCT01544465 - Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease N/A